Proteomic differences with and without ozoneexposure in a smoking-induced emphysema lung model

키워드

참고문헌 (37)

1. "Global Strategy for the Diagnosis, Management and Prevention of COPD 2011" (2013)[URL]
2. Chapman KR, "Epidemiology and costs of chronic obstructive pulmonary disease", Eur Respir J, 27, pp.188~207 (2006)
3. Kim DS, "Prevalence of chronic obstructive pulmonary disease in Korea: a population-based spirometry survey", Am J Respir Crit Care Med, 172, pp.842~847 (2005)
4. Patil SP, "In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease", Arch Intern Med, 163, pp.1180~1186 (2003)
5. Ai-Ping C, "In-hospital and 5-year mortality of patients treated in the ICU for acute exacerbation of COPD: a retrospective study", Chest, 128, pp.518~524 (2005)
6. Berkius J, "Characteristics and long-term outcome of acute exacerbations in chronic obstructive pulmonary disease: an analysis of cases in the Swedish Intensive Care Registry during 2002-2006", Acta Anaesthesiol Scand, 52, pp.759~765 (2008)
7. Medina-Ramon M, "The effect of ozone and PM10 on hospital admissions for pneumonia and chronic obstructive pulmonary disease: a national multicity study", Am J Epidemiol, 163, pp.579~588 (2006)
8. Ko FW, "Temporal relationship between air pollutants and hospital admissions for chronic obstructive pulmonary disease in Hong Kong", Thorax, 62, pp.780~785 (2007)
9. Halonen JI, "Ozone and cause-specific cardiorespiratory morbidity and mortality", J Epidemiol Community Health, 64, pp.814~820 (2010)
10. Ciencewicki J, "Oxidants and the pathogenesis of lung diseases", J Allergy Clin Immunol, 122, pp.456~468 (2008)
11. Barnes PJ., "Alveolar macrophages as orchestrators of COPD", COPD, 1, pp.59~70 (2004)
12. Gerritsen WB, "Markers of inflammation and oxidative stress in exacerbated chronic obstructive pulmonary disease patients", Respir Med, 99, pp.84~90 (2005)
13. Cazzola M, "Outcomes for COPD pharmacological trials: from lung function to biomarkers", Eur Respir J, 31, pp.416~469 (2008)
14. Lomas DA, "Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD", Eur Respir J, 34, pp.95~102 (2009)
15. Magi B, "Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study", Electrophoresis, 23, pp.3434~3444 (2002)
16. Larsen K, "Functional and phenotypical comparison of myofibroblasts derived from biopsies and bronchoalveolar lavage in mild asthma and scleroderma", Respir Res, 7, pp.11~ (2006)
17. Haque R, "The impact of surfactant protein-A on ozone-induced changes in the mouse bronchoalveolar lavage proteome", Proteome Sci, 7, pp.12~ (2009)
18. Luthje L, "Exercise intolerance and systemic manifestations of pulmonary emphysema in a mouse model", Respir Res, 10, pp.7~ (2009)
19. Cha MH, "Proteomic identification of macrophage migration-inhibitory factor upon exposure to TiO2 particles", Mol Cell Proteomics, 6, pp.56~63 (2007)
20. Shevchenko A, "Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels", Anal Chem, 68, pp.850~858 (1996)
21. Wang D, "Experimental pulmonary infection and colonization of Haemophilus influenzae in emphysematous hamsters", Pulm Pharmacol Ther, 23, pp.292~299 (2010)
22. Triantaphyllopoulos K, "A model of chronic inflammation and pulmonary emphysema after multiple ozone exposures in mice", Am J Physiol Lung Cell Mol Physiol, 300, pp.L691~L700 (2011)
23. Kierstein S, "Susceptibility to ozone-induced airway inflammation is associated with decreased levels of surfactant protein D", Respir Res, 7, pp.85~ (2006)
24. Williams AS, "Modulation of ozone-induced airway hyperresponsiveness and inflammation by interleukin-13", Eur Respir J, 32, pp.571~578 (2008)
25. Seaman MN, "Membrane recruitment of the cargo-selective retromer subcomplex is catalysed by the small GTPase Rab7 and inhibited by the Rab-GAP TBC1D5", J Cell Sci, 122(Pt 14), pp.2371~2382 (2009)
26. Shimi T, "The A- and B-type nuclear lamin networks: microdomains involved in chromatin organization and transcription", Genes Dev, 22, pp.3409~3421 (2008)
27. Valenca SS, "Lung morphometry and MMP-12 expression in rats treated with intraperitoneal nicotine", Exp Toxicol Pathol, 55, pp.393~400 (2004)
28. Wright JL, "Animal models of chronic obstructive pulmonary disease", Am J Physiol Lung Cell Mol Physiol, 295, pp.L1~L15 (2008)
29. Szabari MV, "Acute mechanical forces cause deterioration in lung structure and function in elastase-induced emphysema", Am J Physiol Lung Cell Mol Physiol, 303, pp.L567~L574 (2012)
30. Liu ZB, "Orexin-A and respiration in a rat model of smoke-induced chronic obstructive pulmonary disease", Clin Exp Pharmacol Physiol, 37, pp.963~968 (2010)
31. Duan MC, "Mechanisms and dynamics of Th17 cells in mice with cigarette smoke-induced emphysema", Zhonghua Yi Xue Za Zhi, 91, pp.1996~2000 (2011)
32. Manoli SE, "Maternal smoking and the retinoid pathway in the developing lung", Respir Res, 13, pp.42~ (2012)
33. Churg A, "Tumor necrosis factor-alpha drives 70% of cigarette smoke-induced emphysema in the mouse", Am J Respir Crit Care Med, 170, pp.492~498 (2004)
34. Churg A, "alpha-1-Antitrypsin ameliorates cigarette smoke-induced emphysema in the mouse", Am J Respir Crit Care Med, 168, pp.199~207 (2003)
35. Guerassimov A, "The development of emphysema in cigarette smoke-exposed mice is strain dependent", Am J Respir Crit Care Med, 170, pp.974~980 (2004)
36. Cho HY, "Exacerbated airway toxicity of environmental oxidant ozone in mice deficient in Nrf2", Oxid Med Cell Longev, 2013, pp.254069~ (2013)
37. Gunay E, "Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study", Inflammation, 37, pp.374~380 (2014)

관련 논문AI추천